These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36429699)

  • 21. Deep Learning-Based ADHD and ADHD-RISK Classification Technology through the Recognition of Children's Abnormal Behaviors during the Robot-Led ADHD Screening Game.
    Lee W; Lee S; Lee D; Jun K; Ahn DH; Kim MS
    Sensors (Basel); 2022 Dec; 23(1):. PubMed ID: 36616875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Open-label, Self-control, Prospective Study on Cognitive Function, Academic Performance, and Tolerability of Osmotic-release Oral System Methylphenidate in Children with Attention-deficit Hyperactivity Disorder.
    Zheng Y; Liang JM; Gao HY; Yang ZW; Jia FJ; Liang YZ; Fang F; Li R; Xie SN; Zhuo JM
    Chin Med J (Engl); 2015 Nov; 128(22):2988-97. PubMed ID: 26608976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Equine-Assisted Activities and Therapy for Treating Children with Attention-Deficit/Hyperactivity Disorder.
    Jang B; Song J; Kim J; Kim S; Lee J; Shin HY; Kwon JY; Kim YH; Joung YS
    J Altern Complement Med; 2015 Sep; 21(9):546-53. PubMed ID: 26167851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of atomoxetine in children with severe autistic disorders and symptoms of ADHD: an open-label study.
    Charnsil C
    J Atten Disord; 2011 Nov; 15(8):684-9. PubMed ID: 20686100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of methylphenidate on body index and physical fitness in Korean children with attention deficit hyperactivity disorder.
    Kang KD; Yun SW; Chung U; Kim TH; Park JH; Park IH; Han DH
    Hum Psychopharmacol; 2016 Mar; 31(2):76-82. PubMed ID: 26756111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aripiprazole in children with attention-deficit/hyperactivity disorder.
    Findling RL; Short EJ; Leskovec T; Townsend LD; Demeter CA; McNamara NK; Stansbrey RJ
    J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):347-54. PubMed ID: 18759644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Open-Label Dose Optimization of Methylphenidate Extended-Release Orally Disintegrating Tablet in a Laboratory Classroom Study of Children with Attention-Deficit/Hyperactivity Disorder.
    Childress AC; Kollins SH; Cutler AJ; Marraffino A; Sikes CR
    J Child Adolesc Psychopharmacol; 2021 Jun; 31(5):342-349. PubMed ID: 34081560
    [No Abstract]   [Full Text] [Related]  

  • 29. Impact of a behavioural sleep intervention on symptoms and sleep in children with attention deficit hyperactivity disorder, and parental mental health: randomised controlled trial.
    Hiscock H; Sciberras E; Mensah F; Gerner B; Efron D; Khano S; Oberklaid F
    BMJ; 2015 Jan; 350():h68. PubMed ID: 25646809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment response and remission in a double-blind, randomized, head-to-head study of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit hyperactivity disorder.
    Dittmann RW; Cardo E; Nagy P; Anderson CS; Adeyi B; Caballero B; Hodgkins P; Civil R; Coghill DR
    CNS Drugs; 2014 Nov; 28(11):1059-69. PubMed ID: 25038977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of atomoxetine as add-on to psychoeducation in the treatment of attention deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled study in stimulant-naïve Swedish children and adolescents.
    Svanborg P; Thernlund G; Gustafsson PA; Hägglöf B; Poole L; Kadesjö B
    Eur Child Adolesc Psychiatry; 2009 Apr; 18(4):240-9. PubMed ID: 19156355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical symptoms and performance on the Continuous Performance Test in children with attention deficit hyperactivity disorder between subtypes: a natural follow-up study for 6 months.
    Wang LJ; Huang YS; Chiang YL; Hsiao CC; Shang ZY; Chen CK
    BMC Psychiatry; 2011 Apr; 11():65. PubMed ID: 21504587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EEG Neurofeedback Training in Children With Attention Deficit/Hyperactivity Disorder: A Cognitive and Behavioral Outcome Study.
    Shereena EA; Gupta RK; Bennett CN; Sagar KJV; Rajeswaran J
    Clin EEG Neurosci; 2019 Jul; 50(4):242-255. PubMed ID: 30453757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Val/Val genotype of brain-derived neurotrophic factor (BDNF) Val⁶⁶Met polymorphism is associated with a better response to OROS-MPH in Korean ADHD children.
    Kim BN; Cummins TD; Kim JW; Bellgrove MA; Hong SB; Song SH; Shin MS; Cho SC; Kim JH; Son JW; Shin YM; Chung US; Han DH
    Int J Neuropsychopharmacol; 2011 Nov; 14(10):1399-410. PubMed ID: 21733227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of the Prevention Program for Externalizing Problem Behavior (PEP) in Preschoolers with Severe and No or Mild ADHD Symptoms.
    Eichelberger I; Plücka J; Hautmann C; Hanisch C; Döpfner M
    Z Kinder Jugendpsychiatr Psychother; 2016; 44(3):231-9. PubMed ID: 27216329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parental perceived benefits of OROS-methylphenidate treatment for the child with attention-deficit/hyperactivity disorder and for parents themselves.
    Kim JW; Park S; Kim BN; Shin MS; Cho SC; Kim JH; Son JW; Shin YM; Chung US; Han DH
    Pharmacopsychiatry; 2013 Jun; 46(4):137-46. PubMed ID: 23364873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial.
    Kelsey DK; Sumner CR; Casat CD; Coury DL; Quintana H; Saylor KE; Sutton VK; Gonzales J; Malcolm SK; Schuh KJ; Allen AJ
    Pediatrics; 2004 Jul; 114(1):e1-8. PubMed ID: 15231966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attention deficit hyperactivity symptoms and internet addiction.
    Yoo HJ; Cho SC; Ha J; Yune SK; Kim SJ; Hwang J; Chung A; Sung YH; Lyoo IK
    Psychiatry Clin Neurosci; 2004 Oct; 58(5):487-94. PubMed ID: 15482579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of atomoxetine hydrochloride in Korean adults with attention-deficit hyperactivity disorder.
    Lee SI; Song DH; Shin DW; Kim JH; Lee YS; Hwang JW; Park TW; Yook KH; Lee JI; Bahn GH; Hirata Y; Goto T; Takita Y; Takahashi M; Lee S; Treuer T
    Asia Pac Psychiatry; 2014 Dec; 6(4):386-96. PubMed ID: 25345739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of attention deficit hyperactivity disorder in children: results of a multicenter, randomized, double-blind, placebo-controlled clinical trial].
    Zavadenko NN; Makushkin EV; Gaynetdinova DD; Kolokolov OV; Malinina EV; Antipenko EA; Sagutdinova ES; Khaletskaya OV; Dmitriev AV; Maslova NN; Mashin VV; Panteleeva MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(11):62-68. PubMed ID: 36440779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.